NCT06948487View on ClinicalTrials.gov

Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis

RecruitingOBSERVATIONAL
Enrollment

12,000

Participants

Timeline

Start Date

June 17, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

June 3, 2027

Conditions
Gastritis
Trial Locations (1)

Unknown

RECRUITING

Masong Kim Internal Medicine Clinic, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT06948487 - Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis | Biotech Hunter | Biotech Hunter